Stages III-IV Gastric Cancer

Apatinib Prolongs Survival in Advanced Gastric Cancer (06-26-2014)

Apatinib significantly improved overall survival according to the results of a phase III study presented at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. Gastric cancer refers to cancer of the stomach. Though gastric... Continue Reading

Ramucirumab Plus Paclitaxel Improves Survival in Metastatic Gastric Cancer (02-21-2014)

Ramucirumab significantly improved both progression-free and overall survival, when added to paclitaxel in second-line therapy for metastatic gastric cancer, according to the results of a study presented at the 2014 Gastrointestinal Cancers Symposium. Gastric... Continue Reading

Ramucirumab Prolongs Survival in Advanced Gastric Cancer (10-28-2013)

The investigational targeted agent ramucirumab prolongs survival in patients with advanced gastric cancer after standard treatments have failed, according to the results of a study published early online in The Lancet. Gastric cancer refers to cancer... Continue Reading

Second-Line Docetaxel Improves Survival in Esophageal and Gastric Cancer (04-3-2013)

Second-line treatment with docetaxel improves overall survival of patients with advanced esophageal and gastric cancer, according to the results of a study presented at the 2013 Gastrointestinal Cancers Symposium in San Francisco. The esophagus is a muscular... Continue Reading

Adjuvant Radiochemotherapy Demonstrates Benefit in Gastric Cancer (09-25-2012)

Adjuvant radiochemotherapy provides strong and persistent benefit in patients who have undergone curative gastric resection, according to the long-term results of a study published in the Journal of Clinical Oncology.[1] Gastric cancer refers to cancer... Continue Reading

XELOX May Improve Survival in Gastric Cancer (06-24-2011)

The chemotherapy regimen referred to as XELOX may improve overall survival compared with observation alone in stages II and III gastric (stomach) cancer; however, data are still immature and longer follow-up is necessary. These results were presented... Continue Reading

Study Evaluates Whole-brain Radiation Following Surgery or Radiosurgery in Cancer Spread to the Brain (11-16-2010)

Results from a randomized Phase III study indicate that whole-brain radiation therapy (WBRT) following removal of one to three brain metastases with surgery or radiosurgery does not improve overall survival or duration of functional independence but does... Continue Reading

Herceptin® Approved for HER2-positive Metastatic Stomach Cancer (11-2-2010)

The U.S. Food and Drug Administration (FDA) has expanded the approval of Herceptin® (trastuzumab) to include the initial treatment of HER2-positive metastatic cancer of the stomach or gastroesophageal junction in combination with chemotherapy.[1] Herceptin... Continue Reading

Afinitor Promising in Treatment of Advanced Gastric Cancer (07-23-2010)

Afinitor® (everolimus) may be a promising treatment option for patients with metastatic gastric cancer who have undergone previous treatment, according to a study published in the Journal of Clinical Oncology. Afinitor is an oral targeted therapy that... Continue Reading

Clinical Trial for Advanced Gastric Cancer Now Enrolling Patients (07-16-2010)

Gastric cancer forms in the tissues and lining of the stomach. Current treatment options include surgery, chemotherapy, and radiation. The current standard of care for metastatic gastric cancer is systemic therapy. Research is ongoing to determine which... Continue Reading

« Previous PageNext Page »